Related Experiment Video
Updated: Jan 5, 2026

07:34
Manipulation of Rhythmic Food Intake in Mice Using a Custom-Made Feeding System
Published on: December 16, 2022
2.8K
Active Time-Restricted Feeding Improved Sleep-Wake Cycle in db/db Mice
Tianfei Hou1, Chanung Wang2, Shreyas Joshi2
1Department of Physiology, University of Kentucky, Lexington, KY, United States.
Frontiers in Neuroscience
|October 18, 2019
Summary
Active time-restricted feeding (ATRF) can help restore normal sleep-wake cycles in diabetic mice. This strategy may offer a new approach for managing diabetes-related sleep disturbances and improving daytime function.
Area of Science:
- Chronobiology
- Metabolic Disorders
- Sleep Science
Background:
- Diabetes is linked to increased sleep disturbance, leading to daytime sleepiness and impaired function.
- Diabetic mouse models (db/db mice) show disrupted sleep-wake cycles, including increased fragmentation and attenuated daily rhythms.
- Active time-restricted feeding (ATRF) is known to benefit metabolic health, but its effect on sleep in diabetes is unclear.
Purpose of the Study:
- To investigate whether ATRF can restore the normal sleep-wake cycle in diabetic mice (db/db).
- To assess the impact of ATRF on circadian and ultradian sleep-wake patterns in a diabetic model.
Main Methods:
- Utilized a non-invasive piezoelectric system to monitor sleep-wake profiles in db/db mice.
- Established baseline sleep patterns with ad libitum feeding (ALF).
- Administered ATRF and analyzed changes in sleep-wake patterns, including circadian and ultradian rhythms.
Main Results:
- Diabetic db/db mice exhibited abnormal sleep patterns, with reduced light-phase sleep and increased, unusually cycled dark-phase sleep.
- Sleep bout length was significantly shortened in db/db mice during both light and 24-hour periods.
- ATRF successfully restored circadian sleep-wake rhythms but suppressed ultradian oscillations in db/db mice.
Conclusions:
- ATRF demonstrates efficacy in normalizing circadian sleep-wake patterns in diabetic mice.
- ATRF may represent a novel therapeutic strategy for addressing diabetes-induced sleep-wake cycle irregularities.
- Further research could explore ATRF's potential to mitigate daytime sleepiness and improve quality of life for diabetic patients.

